Design, synthesis and anti-inflammatory evaluation of aloe-emodin derivatives as potential modulators of Akt, NF-κB and JNK signaling pathways

IF 6 2区 医学 Q1 CHEMISTRY, MEDICINAL
Hai Shang , Jing Guo , Pengtao Wang , Lingyu Li , Yu Tian , Xiaoxue Li , Zhongmei Zou
{"title":"Design, synthesis and anti-inflammatory evaluation of aloe-emodin derivatives as potential modulators of Akt, NF-κB and JNK signaling pathways","authors":"Hai Shang ,&nbsp;Jing Guo ,&nbsp;Pengtao Wang ,&nbsp;Lingyu Li ,&nbsp;Yu Tian ,&nbsp;Xiaoxue Li ,&nbsp;Zhongmei Zou","doi":"10.1016/j.ejmech.2022.114511","DOIUrl":null,"url":null,"abstract":"<div><p><span>To discover novel anti-inflammatory agents, a series of nitrogen-containing derivatives of aloe-emodin were designed and synthesized. The anti-inflammatory activities of all synthesized derivatives were screened by evaluating their inhibitory effects on LPS-induced nitric oxide production in RAW264.7 macrophages. The preliminary structure-activity relationship was determined. Among them, </span><strong>2i</strong> exhibited the best nitric oxide inhibitory activity (IC<sub>50</sub> = 3.15 μM), with no obvious toxicity. Further evaluation of the inhibitory effect of <strong>2i</strong><span> on inflammatory cytokines showed that </span><strong>2i</strong> significantly reduced the levels of TNF-α, IL-1β, IL-6 and PGE2. In addition, <strong>2i</strong><span> markedly downregulated the expression levels of iNOS and COX-2. Preliminary mechanistic studies indicated that the anti-inflammatory effect of </span><strong>2i</strong><span> might be related to the inhibition of the Akt, NF-κB and JNK signaling pathways. Overall, our findings suggested that </span><strong>2i</strong> might be a promising anti-inflammatory agent, or might serve as a new lead compound for the further development of anti-inflammatory agents.</p></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":6.0000,"publicationDate":"2022-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523422004135","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 10

Abstract

To discover novel anti-inflammatory agents, a series of nitrogen-containing derivatives of aloe-emodin were designed and synthesized. The anti-inflammatory activities of all synthesized derivatives were screened by evaluating their inhibitory effects on LPS-induced nitric oxide production in RAW264.7 macrophages. The preliminary structure-activity relationship was determined. Among them, 2i exhibited the best nitric oxide inhibitory activity (IC50 = 3.15 μM), with no obvious toxicity. Further evaluation of the inhibitory effect of 2i on inflammatory cytokines showed that 2i significantly reduced the levels of TNF-α, IL-1β, IL-6 and PGE2. In addition, 2i markedly downregulated the expression levels of iNOS and COX-2. Preliminary mechanistic studies indicated that the anti-inflammatory effect of 2i might be related to the inhibition of the Akt, NF-κB and JNK signaling pathways. Overall, our findings suggested that 2i might be a promising anti-inflammatory agent, or might serve as a new lead compound for the further development of anti-inflammatory agents.

Abstract Image

作为Akt、NF-κB和JNK信号通路潜在调节剂的芦荟大黄素衍生物的设计、合成和抗炎评价
为寻找新型抗炎药,设计合成了一系列含氮的芦荟大黄素衍生物。通过评价合成的衍生物对lps诱导的RAW264.7巨噬细胞一氧化氮生成的抑制作用,筛选其抗炎活性。初步确定了构效关系。其中,2i对一氧化氮的抑制活性最好(IC50 = 3.15 μM),且无明显毒性。进一步评价2i对炎症细胞因子的抑制作用,发现2i显著降低TNF-α、IL-1β、IL-6和PGE2的水平。此外,2i显著下调了iNOS和COX-2的表达水平。初步机制研究表明,2i的抗炎作用可能与抑制Akt、NF-κB和JNK信号通路有关。总之,我们的研究结果表明,2i可能是一种很有前景的抗炎药,或者可能作为抗炎药进一步开发的新的先导化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信